Clinicopathological characteristics and associated factors of idiopathic membranous nephropathy with hyperuricemia: a single-centered cross-sectional study

[1]  Ru Wang,et al.  Anti-Phospholipase A2 Receptor Antibody Expression at Different Stages of Idiopathic Membranous Nephropathy , 2022, International journal of nephrology.

[2]  B. Rovin,et al.  KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.

[3]  Liang Zhao,et al.  Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy , 2021, International Urology and Nephrology.

[4]  Xiaoqiang Ding,et al.  Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis , 2021, Global health action.

[5]  Xiping Xu,et al.  Degree of blood pressure control and the risk of new-onset hyperuricemia in treated hypertensive patients , 2020, Annals of translational medicine.

[6]  Chen Yang,et al.  Research Advances in the Mechanisms of Hyperuricemia-Induced Renal Injury , 2020, BioMed research international.

[7]  V. Jha,et al.  Regulatory B Cells Are Reduced and Correlate With Disease Activity in Primary Membranous Nephropathy , 2020, Kidney international reports.

[8]  A. Hendricks,et al.  Membranous nephropathy: A ten-year journey of discoveries. , 2020, Seminars in diagnostic pathology.

[9]  L. Beck,et al.  Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era , 2019, Pediatric Nephrology.

[10]  Fan Lin,et al.  Serum uric acid is an independent predictor of renal outcomes in patients with idiopathic membranous nephropathy , 2019, International Urology and Nephrology.

[11]  Mei-juan Yang,et al.  Hypertriglyceridemia and hyperuricemia: a retrospective study of urban residents , 2019, Lipids in Health and Disease.

[12]  D. Hong,et al.  Hyperuricemia and its related histopathological features on renal biopsy , 2019, BMC Nephrology.

[13]  Ming-hui Zhao,et al.  Clinical and prognostic significance of glomerular C1q deposits in primary MN. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[14]  Qian Zhou,et al.  Gender-related differences in clinicopathological characteristics and renal outcomes of Chinese patients with IgA nephropathy , 2018, BMC Nephrology.

[15]  I. Mortada.  Hyperuricemia, Type 2 Diabetes Mellitus, and Hypertension: an Emerging Association , 2017, Current Hypertension Reports.

[16]  E. Casiglia,et al.  Asymptomatic hyperuricemia is a strong risk factor for resistant hypertension in elderly subjects from general population. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  Sang-Man Jin,et al.  Change in serum albumin concentration is inversely and independently associated with risk of incident metabolic syndrome. , 2016, Metabolism: clinical and experimental.

[18]  T. Kumagai,et al.  Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease—A Propensity Score Analysis , 2015, PloS one.

[19]  R. Liu,et al.  Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis , 2015, BioMed research international.

[20]  Luxia Zhang,et al.  Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  Y. Kanno,et al.  Uric Acid Level Has a U-Shaped Association with Loss of Kidney Function in Healthy People: A Prospective Cohort Study , 2015, PloS one.

[22]  D. G. Sandor,et al.  The role of complement in membranous nephropathy. , 2013, Seminars in nephrology.

[23]  E. Ritz,et al.  Uric acid and chronic kidney disease: which is chasing which? , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  Kai Huang,et al.  High Serum Uric Acid and Increased Risk of Type 2 Diabetes: A Systemic Review and Meta-Analysis of Prospective Cohort Studies , 2013, PloS one.

[25]  J. Sowers,et al.  Uric Acid - Key Ingredient in the Recipe for Cardiorenal Metabolic Syndrome , 2013, Cardiorenal Medicine.

[26]  W. Pan,et al.  Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: A prospective study , 2013, Arthritis care & research.

[27]  Hong Wang,et al.  Uric acid, hyperuricemia and vascular diseases. , 2012, Frontiers in bioscience.

[28]  G. Bellomo,et al.  ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease Association of Uric Acid With Change in Kidney Function in Healthy Normotensive Individuals , 2010 .

[29]  G. Lippi,et al.  Epidemiological Association between Uric Acid Concentration in Plasma, Lipoprotein(a), and the Traditional Lipid Profile , 2010, Clinical cardiology.

[30]  T. Balasubramanian.  Uric Acid or 1-Methyl Uric Acid in the Urinary Bladder Increases Serum Glucose, Insulin, True Triglyceride, and Total Cholesterol Levels in Wistar Rats , 2003, TheScientificWorldJournal.

[31]  Agnes B Fogo,et al.  Approach to renal biopsy. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  K. Suzuki,et al.  Risk factors for the incidence of hyperuricaemia: a 6-year longitudinal study of middle-aged Japanese men. , 1999, International journal of epidemiology.